EuroAPI Logo

EuroAPI

Global manufacturer of APIs and CDMO services for human and animal health partners worldwide.

EAPI | PA

Overview

Corporate Details

ISIN(s):
FR0014008VX5 (+2 more)
LEI:
9695002FT7GGI3CKKJ14
Country:
France
Address:
15 RUE TRAVERSIERE, 75012 PARIS
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

EuroAPI is a leading global manufacturer of Active Pharmaceutical Ingredients (APIs). Spun off from Sanofi, the company leverages a unique European industrial network of six production sites to serve healthcare partners in over 80 countries. It offers one of the industry's largest portfolios, with approximately 200 APIs for human and animal health, and holds a leading position in small molecules. In addition to its extensive API catalog, EuroAPI provides Contract Development and Manufacturing Organization (CDMO) services for innovative companies, developing and producing more complex molecules. The company is focused on reliability, high-quality production standards, and regulatory compliance.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-30 17:45
Board/Management Information
Evolution de la composition du Conseil d’administration
French 535.7 KB
2025-09-30 17:45
Board/Management Information
Change in Board’s Composition
English 537.6 KB
2025-07-31 18:30
Report Publication Announcement
Mise à disposition du Rapport financier semestriel 2025
French 444.9 KB
2025-07-31 18:30
Report Publication Announcement
Availability of 2025 Half-Year Financial Report
English 442.4 KB
2025-06-30 17:58
M&A Activity
EUROAPI cède le site de Haverhill à Particle Dynamics dans le cadre du plan de …
French 531.0 KB
2025-06-30 17:58
M&A Activity
EUROAPI sells Haverhill site to Particle Dynamics as part of its FOCUS-27 trans…
English 704.7 KB
2025-06-17 17:02
Major Shareholding Notification
Franchissement de seuils
French 124.2 KB
2025-06-17 16:46
Major Shareholding Notification
Franchissement de seuils
French 104.6 KB
2025-06-04 17:45
Board/Management Information
Frédéric Robert appointed EUROAPI’s Chief Commercial Officer overseeing API Sol…
English 704.4 KB
2025-06-04 17:45
Board/Management Information
EUROAPI nomme Frédéric Robert au poste de Directeur commercial en charge des ac…
French 529.1 KB
2025-05-21 17:45
Post-Annual General Meeting Information
Assemblée Générale Mixte du 21 mai 2025
French 522.9 KB
2025-05-21 17:45
Post-Annual General Meeting Information
Combined General Meeting of May 21, 2025
English 722.2 KB
2025-04-29 17:40
Pre-Annual General Meeting Information
Assemblée Générale mixte du 21 mai 2025 - Modalités de mise à disposition ou de…
French 500.7 KB
2025-04-29 17:40
Pre-Annual General Meeting Information
Combined General Meeting of May 21, 2025 - Availability of preparatory documents
English 618.8 KB
2025-04-29 00:00
Pre-Annual General Meeting Information
Communiqué de mise à disposition des documents préparatoires relatifs à l'Assem…
French 500.7 KB

Automate Your Workflow. Get a real-time feed of all EuroAPI filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for EuroAPI via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.